Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DiaMedica Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
DiaMedica Therapeutics

DiaMedica Therapeutics

Public

DiaMedica Therapeutics, a clinical-stage biopharmaceutical company, develops treatments for strokes and kidney disease.

HQ
Minneapolis, MN, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Founded in Minneapolis, Minnesota, DiaMedica Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for acute ischemic strokes and diabetic kidney disease. The company's core mission is to improve the lives of patients suffering from these severe medical conditions through groundbreaking pharmaceutical solutions. DiaMedica's primary product in development is DM199, a recombinant form of the human protein KLK1, which is currently undergoing pivotal Phase 2 trials.

DiaMedica Therapeutics has garnered attention from notable investors and industry leaders due to its promising research and development efforts. The company has achieved significant milestones, including the successful dosing of the first patient in its ReMEDy2 trial for DM199. This progress underscores DiaMedica's potential impact on stroke and kidney disease treatment, positioning it as a key player in the biopharmaceutical landscape.

DiaMedica Therapeutics - Similar Companies

Neumedics logo

Neumedics

MDI Therapeutics logo

MDI Therapeutics

Dianomi Therapeutics logo

Dianomi Therapeutics

NephroDI Therapeutics logo

NephroDI Therapeutics

nephrodi.com

Medinox logo

Medinox

medinox.com

MediciNova logo

MediciNova

medicinova.com

Intellimedix logo

Intellimedix

StimCell Energetics logo

StimCell Energetics

cellmedx.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Madeira Therapeutics logo

Madeira Therapeutics

Dmed logo

Dmed

dmedglobal.com

Link Medicine logo

Link Medicine

linksciences.com

Medison Pharma logo

Medison Pharma

medisonpharma.com

Diramed logo

Diramed

OrphoMed logo

OrphoMed

DiaMedica Therapeutics - Quick Facts

Who are DiaMedica Therapeutics' competitors?

Companies similar to DiaMedica Therapeutics include Neumedics, MDI Therapeutics, Dianomi Therapeutics and NephroDI Therapeutics.

When was DiaMedica Therapeutics founded?

DiaMedica Therapeutics was founded in 2000.

Where is DiaMedica Therapeutics' headquarters located?

DiaMedica Therapeutics' headquarters is located in Minneapolis, MN, US.

When was DiaMedica Therapeutics' last funding round?

DiaMedica Therapeutics' most recent funding round was for $37.5M (USD) in June 2023.

How much has DiaMedica Therapeutics raised to-date?

As of Jun 21, 2023, DiaMedica Therapeutics has raised a total of $125.7M (USD).

How many employees does DiaMedica Therapeutics have?

DiaMedica Therapeutics has 14 employees as of Feb 6, 2024.

DiaMedica Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001401040
  • ticker: DMAC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research